%0 Journal Article
%T Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea
%A Ahlm Kwon
%A Bo Young Hong
%A Dae-Hyun Jang
%A Eunhee Han
%A Hayoung Choi
%A Hyojin Chae
%A In Goo Lee
%A In Kyung Sung
%A Ji Yoon Han
%A Jiyeon Kim
%A Joo Hyun Park
%A Joonhong Park
%A Jung Hyun Lee
%A Jung-Ok Son
%A Myungshin Kim
%A Sang-Jee Lee
%A So Young Kim
%A Woori Jang
%A Yeonsook Moon
%A Yonggoo Kim
%J Archive of "Annals of Laboratory Medicine".
%D 2019
%R 10.3343/alm.2019.39.3.299
%X To validate the clinical application of chromosomal microarray analysis (CMA) as a first-tier clinical diagnostic test and to determine the impact of CMA results on patient clinical management, we conducted a multicenter prospective study in Korean patients diagnosed as having developmental delay/intellectual disability (DD/ID), autism spectrum disorders (ASD), and multiple congenital anomalies (MCA)
%K Chromosomal microarray analysis
%K Pathogenic
%K Variant of possible significance
%K Variant of unknown significance
%K Benign
%K Clinical management
%K Developmental delay
%K Intellectual disability
%K Autism spectrum disorders
%K Multiple congenital anomalies
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340852/